The first study of its kind has revealed that members of the UK South Asian community are far less likely than non-Asians to take up invitations for bowel or breast cancer screening, while other work has suggested that cancer diagnosis and treatment information should be tailored in a culturally sensitive manner as British Asian and White patients differ in their reactions to cancer diagnosis.
We need to understand how different ethnic groups cope with cancer and what beliefs they hold about the disease to avoid perpetuating the racial inequalities that currently exist with regards to cancer prevention, screening and treatment, says Karen Lord, Clinical Nurse Specialist at the Palliative Care Team, University Hospitals of Leicester.
In this month’s Science & Public Affairs, she discusses the results from two pilot studies that reveal British Asian patients are more likely to disbelieve their diagnosis than British White patients, and also that the two populations differ in how they would prefer to be told they have cancer. A two-year study by researchers at the University of Leicester, with support from research charity Hope Against Cancer, now seeks to build on this work, with a view to improving psychological support services for our increasingly diverse population.
While 31 per cent of White patients in the preliminary study exhibited denial about their cancer diagnosis, this rose to 48 per cent in the British Asian population. Asian patients were also found to have a more fatalistic attitude towards their diagnosis. Such beliefs may have a detrimental effect on a patient’s ability to cope with the experience of cancer, and denial was strongly associated with anxiety and depression.
In a second study looking at the informational needs of patients, it was discovered that Asian patients, in contrast to White patients, would prefer to receive the cancer diagnosis from their GP rather than the hospital consultant.
Over the next two years, 200 White and 200 Asian patients diagnosed with a variety of different cancers will be recruited from the Leicestershire Cancer Centre to further examine core concepts of distress and denial. They will be asked to complete a set of questionnaires over a period of nine months to investigate whether patients alter the way they cope over time and whether their use of denial as a coping strategy decreases. The study also seeks to understand the beliefs patients hold about the causes and curability of cancer – whether they differ between White and South Asian individuals, and whether cancer means different things in different cultures. For example, there is no similar word for cancer used in Gujarati.
‘This research will help us to focus and deliver information about cancer and its treatment in a culturally sensitive manner,’ says Miss Lord. ‘The findings of this study should lead to improvements in support services for Asian patients suffering from cancer.’
In a related article in this month’s magazine, Ala Szczepura, Professor of Health Services Research at the University of Warwick, comments on the need to promote racial equality for cancer screening. Her work has revealed that members of the UK South Asian community are only half as likely as non-Asians to take up an invitation for bowel cancer screening, and 15 per cent less likely to attend breast cancer screening. The research, which also highlights that uptake differs between South Asian groups, suggests that the inequalities are a result of cultural differences and language needs.
‘It is the first study of its kind, and highlights the need for a national audit system to examine ethnic variations in screening uptake and five-year survival,’’ says Professor Szczepura. ‘Methods for improving uptake need to be identified.’
Lisa Hendry | alfa
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
Pain: Perception and motor impulses arise in the brain independently of one another
12.12.2018 | Technische Universität München
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
12.12.2018 | Health and Medicine
12.12.2018 | Physics and Astronomy
12.12.2018 | Health and Medicine